Gastroenterology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() |
---|
The human major histocompatibility complex (MHC)
on chromosome 6 encodes three classical class I genes: human leukocyte
antigen-A (HLA-A), HLA-B, and HLA-C. These polymorphic genes encode a
43- to 45-kDa cell surface glycoprotein that, in association with the
12-kDa 2-microglobulin
molecule, functions in the presentation of nine amino acid peptides to
the T cell receptor of CD8-bearing T lymphocytes and killer inhibitory
receptors on natural killer cells. In addition to these ubiquitously
expressed polymorphic proteins, the human genome also encodes a number
of nonclassical MHC class I-like, or class Ib, genes that in general
encode nonpolymorphic molecules involved in a variety of specific
immunologic functions. Many of these genes, including CD1, the neonatal
Fc receptor for immunoglobulin G, HLA-G, the MHC class I chain-related
gene A, and Hfe, are prominently
displayed on epithelial cells, suggesting an important role in
epithelial cell biology.
epithelium; intestine; major histocompatibility complex
![]() |
ARTICLE |
---|
![]() ![]() ![]() ![]() |
---|
IT IS INCREASINGLY recognized that epithelial cells, especially intestinal epithelial cells (IECs), play an important role in innate and adaptive immune functions in addition to their important barrier, absorption, and transport functions (13). A structural motif that is particularly useful to the epithelial cells in fulfilling these immunologic functions is provided by the major histocompatibility complex (MHC) class I-related molecules. Through understanding the composition of these molecules, we can gain insight into their possible functions in epithelial cells.
The basic structure of the MHC class I-related molecules reflects that
encoded by the classical MHC class I, or class Ia, genes (14, 32).
These genes are encoded within the MHC class I locus on human
chromosome 6 and consist of the human leukocyte antigen-A (HLA-A),
HLA-B, and HLA-C genes. The open reading frame of these genes consists
of structural domains encoded by discrete exons that translate into a
~43- to 45-kDa glycoprotein containing three membrane distal domains
(1,
2, and
3), a transmembrane domain,
and a cytoplasmic tail. The most membrane-proximal ectodomain, the
3 domain, provides the major
contact sites for the noncovalently associated 12-kDa
2-microglobulin
(
2m)
molecule, which is encoded outside the MHC class I locus (38).
2m coassociation with the MHC
class I heavy chain is prerequisite for functional expression of the
protein complex on the cell surface. The most membrane distal
1 and
2 domains contribute to the
formation of a series of
-pleated sheets bounded on the sides by two
-helices, forming a groove consisting of a series of pockets capable
of binding nine amino acid peptides for presentation to the T-cell
receptor (TCR) of CD8-bearing T cells (4, 14). In making contact with the
-helices and peptide of the
1 and
2 domains, stabilized by
interactions between CD8 on the T cell and clusters of amino acids
within the
3 domain of the MHC
class Ia molecule (10), the T cell is activated to fulfill its effector
function, whether it be proliferation, cytolysis, and/or
cytokine secretion. Because the peptides contained within the groove of
the MHC class Ia molecules are predominantly derived from the
degradation of intracellular molecules by proteasomes, CD8+ T cells are
concerned with monitoring the intracellular health of MHC class
Ia-bearing cells such as epithelial cells. Delivery of peptides to the
MHC class Ia molecule-
2m complex is assisted by endoplasmic reticulum-associated proteins, transporters associated with antigen presentation, TAP1 and TAP2 (18). The vast majority of intraepithelial lymphocytes
that reside above the basal lamina adjacent to the basolateral surface of the epithelial cells of the intestine are CD8+, indicating the
potential importance of this pathway in dealing with deleterious intracellular events as might occur during viral infection, cellular stress, and neoplastic transformation, common events for epithelial cells (5). The MHC class Ia genes display significant allelic polymorphism, due to variations in the amino acid composition of the
1 and
2 domains, each capable of
binding a slightly different large array of nonameric peptides (32). In
addition, each individual is endowed with six different alleles,
predicting that the peptide-binding capacity of an individual is
enormous and well suited to dealing with unforeseen antigenic assaults.
This pathway of antigen presentation is so efficient that
microorganisms, especially viruses, have spent a great deal of
evolutionary energy devising strategies to subvert this pathway, such
as through the expression of molecules that interfere with cell surface
display of MHC class Ia molecules (12, 22) and the generation of decoy
molecules encoded by the genome of the pathogen that structurally
resemble the MHC class I molecule (11). The common gastrointestinal
pathogens herpes simplex virus (12) and cytomegalovirus (11) can
accommodate each of these mechanisms of immune evasion, respectively.
The classical MHC class I molecules not only serve as ligands for the TCR of CD8-bearing lymphocytes capable of eliciting cytolysis, but also for killer inhibitory receptors (KIRs) on the cell surface of natural killer (NK) cells (30). When ligated by MHC class Ia, KIRs transmit inhibitory signals to the NK cell bearing the KIR. As a consequence, MHC class Ia-bearing cells are not lysed. However, in the absence of MHC class I, as commonly occurs during neoplasia, including tumors of the epithelium (3), NK-mediated lysis can be induced by ligation of killer-activating receptors (KARs) on the NK cell (30). KIRs exhibit allelic specificity for MHC class Ia molecules, and their binding can be affected by the nonameric peptides presented by specific MHC class Ia alleles. Although NK cells are not a prominent component of the epithelial compartment, the increasing recognition that subsets of T cells, such as so-called natural T cells (29), are capable of expressing KIRs indicates the potential importance of this mechanism of cytolysis induction for T cells and the utility of these regulatory mechanisms at epithelial surfaces.
A plethora of human genes have developed from the ancestral MHC class I
gene due to the general utility of this MHC structure in performing
discrete tasks of immunologic recognition. These MHC class I-related
genes, other than the classical class I genes, are called nonclassical
MHC class I molecules or MHC class Ib molecules (10). The MHC class Ib
molecules are encoded either by genes linked to the classical HLA-A,
HLA-B, and HLA-C genes on chromosome 6 [HLA-E, HLA-F, HLA-G, and HLA-H
and MHC class I chain-related gene A (MICA)] or by genes outside the
MHC class I locus. These latter genes include the CD1 family and a gene of unknown function, MR1 (21), on chromosome 1, the human homologue of
the rodent neonatal Fc receptor for immunoglobulin G (IgG) (FcRn) on
chromosome 19, and the
zinc-2-glycoprotein (ZAG), a soluble serum protein of unknown function (36) encoded on chromosome 7 (Table 1). In mouse species, an even larger
number of MHC-linked genes are encoded within three genetic loci (Q, T,
and M) on chromosome 17 (10).
|
These genes are considered MHC class I like on the basis of
similarities of exon-intron structure with MHC class Ia molecules (1-
3
ectodomains, transmembrane domain, and cytoplasmic tail encoded by
discrete exons) and dependence on
2m for cell surface display and
function, with some exceptions. CD1d (see below), MICA (1, 19), and ZAG
(36) can be expressed without
2m, suggesting an element of
independence from
2m in
function. However, the MHC class Ib molecules differ in their general
lack of polymorphism in the amino acid composition of their respective
1 and
2 domains, so that they are
considered to be nonpolymorphic (10, 32). This lack of polymorphism,
with some exceptions (as described below), suggests that the
1 and
2 domains of the MHC class Ib molecules bind very distinct structures. This further suggests that
they have evolved to specialize in binding evolutionarily conserved
ligands. In conjunction with other structural information encoded in
their primary amino acid sequences, their specific ligand recognition
also correlates with specific types of functions as a consequence of
ligand binding. Finally, the MHC class I molecules, in contrast to the
ubiquitously expressed MHC class Ia molecules, exhibit a restriction in
their expression to specific cell types and, naturally, tissues (10).
This is especially relevant to human epithelial cells, which appear to
be a particularly prominent cell type that exhibits expression of
several MHC class Ib molecules, including CD1, FcRn, HLA-G, MICA, and
HLA-H.
The human CD1 gene family consists of five genes, CD1A-E (8). A gene
product for CD1E has not yet been defined. (By convention, CD1 genes
are represented by capital letters and CD1 proteins by lowercase
letters.) Nucleotide and deduced amino acid homologies predict that
these gene products segregate into two groups: CD1a-c and CD1d. CD1A-C
homologues are not present in mice and rats, which contain CD1D
homologues highly related to human CD1D. Whereas CD1a-c are expressed
by thymocytes and certain professional antigen-presenting cells such as
B lymphocytes, Langerhans' cells of the skin, and activated monocytes,
CD1d is expressed by thymocytes, B cells, hepatocytes, and,
importantly, epithelial cells in a wide variety of organs. CD1b and
CD1c appear to function in the presentation of exogenous and, possibly,
endogenous lipid antigens to T cells (24). In general, these
CD1-restricted lipid-responsive T cells are either CD8+ or lack CD4 and
CD8 (double negative). The response of double-negative cells suggests
either no need for coreceptor function in TCR binding or the use of
another novel, not yet described, coreceptor molecule. The
antigen-presenting pathway by which CD1b and CD1c acquire lipid-related
antigens is TAP independent and overlaps with that utilized by MHC
class II molecules (37). The MHC class II homologies include
similarities in the nucleotide sequence within the
3 domain and the presence of a
YXXZ motif (tyrosine-amino acid-amino acid-hydrophobic amino acid) in
the cytoplasmic tail that controls protein movement to an endocytic compartment in which MHC class II processing occurs. CD1d shares the
YXXZ motif with CD1b and CD1c and exhibits a narrow but deep hydrophobic pocket (40), suggesting a similar but unproven capability of binding and presenting exogenous and/or endogenous lipid
antigens to T cells generated by a processing pathway that bisects MHC class II. However, in contrast to MHC class Ia molecules, CD1d is
clearly stable in the absence of
2m in transfected model systems and possibly in the absence of antigen, raising the possibility for
other immunoregulatory functions of CD1d (Ref. 2; R. S. Blumberg, J. Garcia, H. Kim, D. Gerdes, S. Porcelli, M. Exley, and S. P. Balk, unpublished results). This may be especially
relevant to CD1d function in epithelial cells. In IECs, CD1d
transcription occurs within the lower zones of the crypt epithelium,
with protein expression predominantly on IECs within the upper crypts
and villi (26). Moreover, IEC CD1d is expressed independently of
2m and carbohydrate side chain
modification (2) and recognized by CD8+ T cells (31). Fully
glycosylated,
2m-associated
CD1d appears to be a ligand for an invariant TCR-
chain expressed on
double-negative human T cells bearing NKR-P1A, a KIR (15).
On CD1d ligation, these double-negative T cells secrete high quantities
of interferon-
and interleukin-4, suggesting an important
immunoregulatory function. Whether epithelial cell CD1d performs a
similar immunoregulatory function for local T cells, functions in the
sampling of luminal bacterial antigens for presentation to local T
cells, or performs another function remains to be established
(6).
FcRn was originally defined as the rat receptor expressed by neonatal
IECs responsible for vectorial transport of maternal IgG into neonatal
animals (25). Recent studies with
2m knockout mice support the
role of FcRn in similar functions in mice, confirm the prerequisite
role of
2m association for FcRn
function, and support the role of FcRn in regulating IgG catabolism
through protection of IgG in an endocytic cycling pathway involving
endothelial cells, which also express FcRn. To accomplish these
functions, FcRn has maintained the basic MHC class I structure with
some embellishments. Due primarily to a proline residue at position 162 in the
2 domain, the potential
antigen-binding groove of FcRn is disabled so that binding to its
ligand, the Fc portion of IgG, occurs on the outer face of the
-helices. Interactions between FcRn and IgG are pH dependent
(binding at acidic pH, dissociation at neutral pH) due to charged
residues at the contact sites of FcRn and the hinge region of IgG. As a
result, binding and transport occur at acidic pH, the pH of the
neonatal lumen and endosomes, and release occurs at neutral pH, the pH
of tissue and plasma. In humans, such structural properties are useful
to the syncytiotrophoblast of the placenta, which is responsible for
passive acquisition of maternal IgG by the fetus and from which FcRn
has recently been identified. However, the functional role of FcRn
expression on epithelia during adult rodent life (9) and, especially, the high-level FcRn expression in adult human intestinal epithelium (23) are not clear.
The trophoblastic epithelium of human placenta, which is in direct
contact with maternal tissues, lacks classical MHC class I and class II
(HLA-DR, HLA-DP, and HLA-DQ) proteins, making it susceptible to lysis
by maternal NK cells, which are present in large numbers in human
decidua. This problem may be remedied by the expression of HLA-G on the
syncytiotrophoblast. Although considered a nonclassical MHC class I
molecule linked to the MHC locus on chromosome 6, HLA-G exhibits a
limited amount of allelic polymorphism in the
1 and
2 domains, exhibits
prerequisite dependency on
2m,
and contains
1 and
2 domains that fold into a
groove competent to bind nonameric peptides (28, 39). Recent evidence
also suggests that HLA-G is a relatively public receptor for KIRs
specific for HLA-C (34). Given the possibility that HLA-G is more
widely expressed than originally believed, including perhaps on other epithelial surfaces, it should be considered that these mechanisms of
NK inhibition may be more generally applicable.
MICA is a recently described MHC-linked class Ib molecule that appears
to exhibit relatively restricted expression to intestinal epithelium
and, similar to CD1d, is somewhat indifferent to
2m for cell surface expression
(1, 19). Although the function of MICA remains unknown, a clue may be
provided by the promotor region, which exhibits functional heat shock
response elements (19). This suggests a possible functional role for
MICA as a cell surface flag that provides a danger signal as a
consequence of some ubiquitous stress signal. This would indicate that
local T cells expressing ligands for MICA may possibly be responsible for eliciting a cellular response to epithelial cell injury.
Finally, the newest member of the MHC class Ib group relevant to
epithelial biology is the recently described HLA-H gene product, which
has recently been renamed Hfe (16).
The Hfe gene product is widely
expressed through the gastrointestinal epithelium, with most prominent
expression in the crypts of the small intestine (33). Mutations of this
protein have been linked to the iron overload disorder hemochromatosis.
Almost all hemochromatosis subjects manifest a cystine 282 tyrosine (C282Y) mutation that disrupts association of
Hfe with
2m and, consequently, cell
surface expression of this molecule (17). Of note, the
Hfe gene also contains iron response
elements. The specific relationship of this allelic variant to iron
transport is unknown but may lie through intermolecular associations
with recently described iron transporters. These iron transporters are
multiple membrane spanners (20). Interestingly, similar molecules, such
as CD82, have been shown to coassociate with MHC class Ia molecules
(27). This raises the possibility that these newly described iron
transporters may coassociate with
Hfe/
2m
to somehow regulate intracellular iron levels. The
specific ligand of Hfe remains to be
determined, and its crystal structure is presently unknown.
In summary, the MHC class I protein structure contains a significant amount of information useful in accomplishing a variety of cellular tasks commonly performed by epithelial cells, specifically in areas of cellular transport (Hfe, FcRn) and regulation of lymphocyte responses to altered epithelial cells (HLA-G, MICA?) and possibly bacterial antigens (CD1). What is unique about the MHC class I-like structure that makes it useful to epithelial cells? It can only be conjectured that its value lies in the ability of these molecules to link specific ligand binding to a variety of hardwired cellular pathways involved in protein trafficking that ultimately result in regulating lymphocyte responses. There is an enormous amount of work still to be done to elucidate the functional mechanisms of these and other yet to be discovered MHC class Ib molecules in epithelial cell biology.
![]() |
ACKNOWLEDGEMENTS |
---|
This study was supported by National Institutes of Health Grants DK-44319, AI-53056, and DK-51362 and by a grant from the Crohn's and Colitis Foundation of America.
![]() |
FOOTNOTES |
---|
* Second in a series of invited articles on Current Concepts in Mucosal Immunity.
Address reprint requests to Gastroenterology Division, Brigham and Women's Hospital, 75 Francis St., Thorn 1410, Boston, MA 02115.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() |
---|
1.
Bahram, S.,
M. Bresnahan,
D. E. Geraghty,
and
T. Spies.
A second lineage of mammalian major histocompatibility complex class I genes.
Proc. Natl. Acad. Sci. USA
91:
6259-6263,
1994[Abstract].
2.
Balk, S. P.,
S. Burke,
J. E. Polischuk,
M. E. Frantz,
L. Yang,
S. Porcelli,
S. P. Colgan,
and
R. S. Blumberg.
2-Microglobulin-independent MHC class 1b molecule expressed by human intestinal epithelium.
Science
265:
259-262,
1994[Medline].
3.
Bicknell, D. C.,
A. Rowan,
and
W. F. Bodmer.
2-Microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.
Proc. Natl. Acad. Sci. USA
91:
4751-4755,
1994[Abstract].
4.
Bjorkman, P. J.,
M. A. Saper,
B. Samraoui,
W. S. Bennett,
J. L. Strominger,
and
D. C. Wiley.
Structure of the human class I histocompatibility antigen, HLA-A2.
Nature
329:
506-518,
1987[Medline].
5.
Blumberg, R. S.,
and
S. P. Balk.
Intraepithelial lymphocytes and their recognition of non-classical MHC molecules.
Int. Rev. Immunol.
11:
15-30,
1994[Medline].
6.
Blumberg, R. S.,
S. P. Colgan,
and
S. P. Balk.
CD1d: outside-in antigen presentation in the intestinal epithelium?
Clin. Exp. Immunol.
109:
223-225,
1997[Medline].
8.
Blumberg, R. S.,
D. Gerdes,
A. Chott,
S. A. Porcelli,
and
S. P. Balk.
Structure and function of the CD1 family of MHC-like cell surface proteins.
In: Immunological Reviews, edited by G. Möller. Copenhagen: Munksgaard, 1995, p. 1-29.
9.
Blumberg, R. S.,
T. Koss,
C. M. Story,
D. Baricani,
J. Polischuk,
A. Lipin,
L. Pablo,
R. Green,
and
N. E. Simister.
A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes.
J. Clin. Invest.
95:
2397-2402,
1995[Medline].
10.
Blumberg, R. S.,
N. Simister,
A. D. Christ,
E. J. Israel,
S. P. Colgan,
and
S. P. Balk.
MHC-like molecules on mucosal epithelial cells.
In: Essentials of Mucosal Immunology, edited by M. F. Kagnoff,
and H. Kiyono. San Diego: Academic, 1996, p. 85-99.
11.
Browne, H.,
G. Smith,
S. Beck,
and
T. Minson.
A complex between the MHC class I homologue encoded by human cytomegalovirus and 2 microglobulin.
Nature
346:
770-772,
1990.
12.
Burgert, H.-G.,
and
S. Kvist.
The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition.
EMBO J.
6:
2019-2026,
1987[Abstract].
13.
Christ, A. D.,
and
R. S. Blumberg.
The intestinal epithelial cell: immunological aspects.
Springer Semin. Immunopathol.
18:
449-461,
1997[Medline].
14.
Engelhard, V. H.
Structure of peptides associated with MHC class I molecules.
Curr. Opin. Immunol.
6:
13-23,
1994[Medline].
15.
Exley, M.,
J. Garcia,
S. P. Balk,
and
S. Porcelli.
Requirements for CD1d recognition by human invariant V24+ CD4
CD8
T cells.
J. Exp. Med.
186:
1-11,
1997
16.
Feder, J. N.,
A. Gnirke,
W. Thomas,
Z. Tsuchihashi,
D. A. Ruddy,
A. Basava,
F. Dormishian,
R. Domingo, Jr.,
M. C. Ellis,
A. Fullan,
L. M. Hinton,
N. L. Jones,
B. E. Kimmel,
G. S. Kronmal,
P. Lauer,
V. K. Lee,
D. B. Loeb,
F. A. Mapa,
E. McClelland,
N. C. Meyer,
G. A. Mintier,
N. Moeller,
T. Moore,
E. Morikang,
C. E. Prass,
L. Quintana,
S. M. Starnes,
R. C. Schatzman,
K. J. Brunke,
D. T. Drayna,
N. J. Risch,
B. R. Bacon,
and
R. K. Wolff.
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.
Nat. Genet.
13:
399-408,
1996[Medline].
17.
Feder, J. N.,
Z. Tsuchihashi,
A. Irrinki,
V. K. Lee,
F. A. Mapa,
E. Morikang,
C. E. Prass,
M. Starnes,
R. K. Wolff,
S. Parkkila,
W. S. Sly,
and
R. C. Schatzman.
The hemochromatosis founder mutation in HLA-H disrupts 2-microglobulin interaction and cell surface expression.
J. Biol. Chem.
272:
14025-14028,
1997
18.
Germain, R. N.
MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.
Cell
76:
287-299,
1994[Medline].
19.
Groh, V.,
S. Bahram,
S. Bauer,
A. Herman,
M. Beauchamp,
and
T. Spies.
Cell stress-related human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.
Proc. Natl. Acad. Sci. USA
93:
12445-12450,
1996
20.
Gunshin, H.,
B. Mackenzie,
U. V. Berger,
Y. Gunshin,
M. F. Romero,
W. F. Boron,
S. Nussberger,
J. L. Gollan,
and
M. A. Hediger.
Cloning and characterization of a mammalian proton-coupled metal-ion transporter.
Nature
388:
482-488,
1997[Medline].
21.
Hashimoto, K.,
M. Hirai,
and
Y. Kurosawa.
A gene outside the human MHC related to classical HAL class I genes.
Science
269:
693-695,
1995[Medline].
22.
Hill, A. B.,
B. C. Barnett,
A. J. McMichael,
and
D. J. McGeoch.
HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2.
J. Immunol.
152:
2736-2741,
1994
23.
Israel, E. J.,
S. Taylor,
Z. Wu,
E. Mizoguchi,
A. Bahn,
R. S. Blumberg,
and
N. E. Simister.
Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells.
Immunology.
92:
69-74,
1997[Medline].
24.
Jullien, D.,
S. Stenger,
W. A. Ernst,
and
R. L. Modlin.
CD1 presentation of microbial nonpeptide antigens to T cells.
J. Clin. Invest.
99:
2071-2074,
1997
25.
Junghans, R. P.
Finally! The Brambell receptor (FcRB): mediator of transmission of immunity and protection from catabolism for IgG.
Immunol. Res.
16:
29-57,
1997[Medline].
26.
Kasai, K.,
A. Matsuura,
K. Kikuchi,
Y. Hashimoto,
and
S. Ichimiya.
Localization of rat CD1 transcripts and protein in rat tissues: an analysis of rat CD1 expression by in situ hybridization and immunohistochemistry.
Clin. Exp. Immunol.
109:
317-322,
1997[Medline].
27.
Lagaudrière-Gesbert, C.,
S. Lebel-Binay,
E. Wiertz,
H. L. Ploegh,
D. Fradelizi,
and
H. Conjeaud.
The tetraspanin protein CD82 associates with both free HAL class I heavy chain and heterodimeric 2-microglobulin complexes.
J. Immunol.
158:
2790-2797,
1997[Abstract].
28.
Lee, N.,
A. R. Malacko,
A. Ishitani,
M.-C. Chen,
J. Bajorath,
H. Marquardt,
and
D. E. Geraghty.
The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association.
Immunity
3:
591-600,
1995[Medline].
29.
MacDonald, H. R.
NK1.1+ T cell receptor-/
+ cells: new clues to their origin, specificity, and function.
Curr. Opin. Immunol.
7:
633-638,
1995.
30.
Moretta, A.,
R. Biassoni,
C. Bottino,
D. Pende,
M. Vitale,
A. Poggi,
M. C. Mingari,
and
L. Moretta.
Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes.
In: Immunological Reviews, edited by P. Parham. Copenhagen: Munksgaard, 1997, p. 105-117.
31.
Panja, A.,
R. S. Blumberg,
S. P. Balk,
and
L. Mayer.
CD1d is involved in T cell-intestinal epithelial cell interactions.
J. Exp. Med.
178:
1115-1119,
1993[Abstract].
32.
Parham, P.
The rise and fall of great class I genes.
Semin. Immunol.
6:
373-382,
1994[Medline].
33.
Parkkila, S.,
A. Waheed,
R. S. Britton,
J. N. Feder,
Z. Tsuchihashi,
R. C. Schatzman,
B. R. Bacon,
and
W. S. Sly.
Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique patterns of expression in gastrointestinal tract.
Proc. Natl. Acad. Sci. USA
94:
2534-2539,
1997
34.
Pazmany, L.,
O. Mandelboim,
M. Valés-Gómez,
D. M. Davis,
H. T. Reyburn,
and
J. L. Strominger.
Protection from natural killer cell-mediated lysis by HLA-G expression on target cells.
Science
274:
792-795,
1996
35.
Salter, R. D.,
R. J. Benjamin,
P. K. Wesley,
S. E. Buxton,
T. P. J. Garrett,
C. Clayberger,
A. M. Krensky,
A. M. Norment,
D. R. Littman,
and
P. Parham.
A binding site for the T-cell co-receptor CD8 on the 3 domain of HLA-A2.
Nature
345:
41-46,
1990[Medline].
36.
Sánchez, L. M.,
C. López-Orín,
and
P. J. Bjorkman.
Biochemical characterization and crystallization of human Zn-2-glycoprotein, a soluble class I major histocompatibility complex homolog.
Proc. Natl. Acad. Sci. USA
94:
46216-46230,
1997.
37.
Sugita, M.,
R. M. Jackman,
E. van Donselaar,
S. M. Behar,
R. A. Rogers,
P. J. Peters,
M. B. Brenner,
and
S. A. Porcelli.
Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs.
Science
273:
349-352,
1996[Abstract].
38.
Tysoe-Calnon, A.,
J. E. Grundy,
and
S. J. Perkins.
Molecular comparisons of the 2-microglobulin-binding site in class I major-histocompatibility-complex
-chains and proteins of related sequences.
Biochem. J.
277:
359-369,
1991[Medline].
39.
Van der Ven, K.,
and
C. Ober.
HLA-G polymorphisms in African Americans.
J. Immunol.
153:
5628-5633,
1994
40.
Zeng, Z.-H.,
A. R. Castaño,
B. W. Segelke,
E. A. Stura,
P. A. Peterson,
and
I. A. Wilson.
Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove.
Science
277:
339-345,
1997